Go Pro
NYSE:CHE

Chemed (CHE) Stock Price, News & Analysis

Chemed logo
$533.03 +0.78 (+0.15%)
Closing price 07/31/2026 03:59 PM Eastern
Extended Trading
$532.18 -0.85 (-0.16%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Chemed Stock (NYSE:CHE)

Advanced

Key Stats

Today's Range
$522.49
$535.94
50-Day Range
$417.62
$537.58
52-Week Range
$365.20
$551.68
Volume
221,552 shs
Average Volume
167,486 shs
Market Capitalization
$7.07 billion
P/E Ratio
26.77
Dividend Yield
0.45%
Price Target
$530.75
Consensus Rating
Hold

Company Overview

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services. Technicians are available around the clock to address emergency repairs, clogged drains, sewer line blockages and water damage mitigation. Roto-Rooter’s service network extends to more than 250 locations nationwide, with a focus on rapid response times and customer satisfaction. The segment also provides preventive maintenance programs designed to help homeowners and businesses protect their plumbing systems.

Vitas Healthcare is one of the nation’s leading providers of end-of-life care, offering hospice and palliative services to terminally ill patients and their families. With a multidisciplinary care model that includes physicians, nurses, social workers, chaplains and trained volunteers, Vitas delivers personalized clinical support, symptom management and emotional counseling. The company also provides bereavement and caregiver support programs, reflecting an emphasis on compassionate, patient-centered care across more than 20 states.

Under the leadership of Chairman and Chief Executive Officer Kenneth C. Brault, Chemed has continued to expand its service capabilities and geographic reach. The company combines strong operational expertise with a commitment to quality, safety and ethical standards. By focusing on critical home services through Roto-Rooter and integrated hospice care via Vitas Healthcare, Chemed aims to address essential needs of American households and vulnerable patient populations.

AI Generated. May Contain Errors.

Chemed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
76th Percentile Overall Score

CHE MarketRank™: 

Chemed scored higher than 76% of companies evaluated by MarketBeat, and ranked 163rd out of 894 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Chemed has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on no strong buy ratings, 1 buy rating, 5 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for Chemed is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Chemed has only been the subject of 4 research reports in the past 90 days.

  • Read more about Chemed's stock forecast and price target.
  • Earnings Growth

    Earnings for Chemed are expected to grow by 9.79% in the coming year, from $23.18 to $25.45 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Chemed is 26.77, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 45.98.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Chemed is 26.77, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 282.25.

  • Price to Earnings Growth Ratio

    Chemed has a PEG Ratio of 2.02. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Chemed has a P/B Ratio of 7.71. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    4.41% of the float of Chemed has been sold short.
  • Short Interest Ratio / Days to Cover

    Chemed has a short interest ratio ("days to cover") of 3.63, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Chemed has recently increased by 0.31%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Chemed has a dividend yield of 0.45%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Chemed has been increasing its dividend for 16 years.

  • Dividend Coverage

    The dividend payout ratio of Chemed is 12.05%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Chemed will have a dividend payout ratio of 9.43% next year. This indicates that Chemed will be able to sustain or increase its dividend.

  • Read more about Chemed's dividend.
  • News Sentiment

    Chemed has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 25 news articles for Chemed this week, compared to 4 articles on an average week.
  • MarketBeat Follows

    2 people have added Chemed to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Chemed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $602,554.00 in company stock.

  • Percentage Held by Insiders

    3.33% of the stock of Chemed is held by insiders.

  • Percentage Held by Institutions

    95.85% of the stock of Chemed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Chemed's insider trading history.
Receive CHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CHE Stock News Headlines

Chemed’s VITAS Drives Upbeat Earnings Call
Chemed (NYSE:CHE) Rating Increased to Strong-Buy at Wall Street Zen
Buy this stock tomorrow
Marc Chaikin, founder of Chaikin Analytics, is flagging a little-known company that just secured a partnership with Nvidia - one he believes positions it ahead of Tesla in the autonomous vehicle race. With a market-moving announcement expected on July 31st, Chaikin is urging investors to swap overpriced AI stocks for this under-the-radar name before markets open. He's also releasing a free Hotlist and Hitlist of buy and sell ideas for the second half of 2026.tc pixel
RBC Capital Remains a Hold on Chemed (CHE)
See More Headlines

CHE Stock Analysis - Frequently Asked Questions

Chemed's stock was trading at $427.86 at the beginning of the year. Since then, CHE stock has increased by 24.6% and is now trading at $533.0290.

Chemed Corporation (NYSE:CHE) announced its earnings results on Tuesday, July, 28th. The company reported $6.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.60 by $0.46. The business's quarterly revenue was up 8.8% compared to the same quarter last year.
Read the conference call transcript
.

Chemed's top institutional investors include Legacy Wealth Asset Management LLC (0.02%), Trust Point Inc. (0.02%), Hennion & Walsh Asset Management Inc. (0.01%) and First Heartland Consultants Inc. (0.01%). Insiders that own company stock include Kevin J Mcnamara, Spencer S Lee, David Patrick Williams, Andrea R Lindell, George J Walsh III, Patrick P Grace, Michael D Witzeman, Brian C Judkins and Nicholas Michael Westfall.
View institutional ownership trends
.

Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Chemed investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AUO (AUOTY).

Company Calendar

Record date for 6/16 Dividend
5/28/2026
Ex-Dividend for 6/16 Dividend
5/28/2026
Dividend Payable
6/16/2026
Last Earnings
7/28/2026
Today
8/02/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NYSE:CHE
CIK
19584
Employees
15,811
Year Founded
1970

Price Target and Rating

High Price Target
$590.00
Low Price Target
$475.00
Potential Upside/Downside
-0.4%
Consensus Rating
Hold
Rating Score (0-4)
2.17
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
$19.91
Trailing P/E Ratio
26.77
Forward P/E Ratio
23.00
P/E Growth
2.02
Net Income
$265.24 million
Net Margins
10.60%
Pretax Margin
14.23%
Return on Equity
31.77%
Return on Assets
18.90%

Debt

Debt-to-Equity Ratio
0.17
Current Ratio
0.91
Quick Ratio
0.89

Sales & Book Value

Annual Sales
$2.53 billion
Price / Sales
2.80
Cash Flow
$24.70 per share
Price / Cash Flow
21.58
Book Value
$69.15 per share
Price / Book
7.71

Miscellaneous

Outstanding Shares
13,270,000
Free Float
12,832,000
Market Cap
$7.07 billion
Optionable
Optionable
Beta
0.51

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NYSE:CHE) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners